Related Experiment Videos
Aggressive bone metastases in urachal carcinoma
H K Mohanti1, L Kumar, B M Biswal
1Department of Radiotherapy, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Urologia Internationalis
|January 1, 1996
Summary
Metastatic spread of urachal carcinoma to bone is a significant concern. Adjuvant chemoradiotherapy may improve outcomes for this rare cancer.
Area of Science:
- Oncology
- Urologic Oncology
- Cancer Metastasis
Background:
- Urachal carcinoma is a rare malignancy arising from the urachus, a remnant of the allantois.
- Metastatic spread, particularly to bone, can occur even after initial surgical resection.
- This case highlights the challenges in managing advanced urachal carcinoma.
Observation:
- A 38-year-old female with urachal carcinoma developed extensive bone metastases one year post-surgery.
- The patient underwent radiotherapy and multiagent chemotherapy (methotrexate, vinblastine, Adriamycin, cisplatin).
- Disease progression to the pelvis and skeletal sites was observed.
Findings:
- The patient received palliative radiotherapy and three cycles of chemotherapy.
- Despite treatment, the patient died 28 months after initial presentation due to disease progression.
- Extensive bone metastases indicate a poor prognosis for advanced urachal carcinoma.
Implications:
- Metastatic urachal carcinoma requires careful consideration of adjuvant treatment strategies.
- Chemoradiotherapy may offer a potential benefit in improving outcomes for patients with urachal carcinoma.
- Further research into optimal adjuvant therapies for rare urachal neoplasms is warranted.